Company profile
Inogen, Inc.
NASDAQ: INGN · Healthcare · Medical - Devices
#252 of 1,418 Healthcare companies by revenue50th-percentile growth
EA Score
71BFH 70DQ 79GM 56SS 69
v0.1 · 65/100 weight · provisional
↑ disclosure history, workforce scale · ↓ 3-yr revenue growth, revenue growth (YoY)
Methodology →Revenue TTM
$351.5M
Rev growth YoY (TTM)
+3.4%
Net income (FY)
-$22.7M
Employees
753
as of 2026-09-15
Market cap
$141.6M
as of 2026-09-15
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$295.3M$295.3M2025
Net income-$22.7M-$22.7M2025
Operating income-$30.2M-$30.2M2025
Total assets$298.6M$298.6M2025
Liabilities$106.4M$106.4M2025
Equity$192.2M$192.2M2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Inogen, Inc.’s revenue?
Inogen, Inc. booked $295.3M in FY2025 revenue, growing 5.9% year over year — about the middle of the pack among Healthcare companies we track, at a -7.7% net margin.
Peers · Healthcare
The Beauty Health Company56CEvolus, Inc.58CIronwood Pharmaceuticals, Inc.78B+Rigel Pharmaceuticals, Inc.82B+AngioDynamics, Inc.——Xeris Biopharma Holdings, Inc.64CNeighbors
Santa Barbara →Key facts
CEOKevin R. Smith
SectorHealthcare
IndustryMedical - Devices
HeadquartersGoleta, CA
ExchangeNASDAQ: INGN
Employees753
IPO date2014-02-14
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.